课题基金 / 基金详情

Targeted antigens for novel strategies of vaccination

Targeted antigens for novel strategies of vaccination
新疫苗接种策略的靶向抗原
批准号:
6670806
负责人:
STEPHEN M HEDRICK
金额:
$30.4万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2005-08-31

项目摘要

项目成果

STEPHEN M HEDRICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The process of immunization involves antigen uptake and processing by professional antigen presenting cells (APCs), activation of APCs, and migration of antigen-bearing cells to lymphoid organs. This in turn can result in the activation of T lymphocytes. This process is dependent upon the presence of inflammatory signals usually provided by microbial pattern recognition. Previous work has shown that antibody molecules provide an ideal delivery vehicle for antigen presentation and vaccination. Antibodies can efficiently direct an associated antigen to a particular cellular subset, such as dendritic cells, and simultaneously fulfill the requirement for cellular activation. Depending on the type of dendritic subset targeted, a prediction is that a Th1 or Th2-1ike responses will result. In addition, by altering the molecular form of the antigenic Ig molecules, and specifying a target receptor, antigen may be directed into either the MHC class I or MHC class II antigen presentation pathways. This proposal describes experiments to establish the basic principles of antibody-directed antigen presentation leading to immunization. More importantly, the experiments will lead to the design of a new generation of vaccines capable of directing the class and thus the effectiveness of immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammation, Insulin Resistance, and Foxo factors
Inflammation, Insulin Resistance, and Foxo factors
A molecular basis for control of T cell memory
A molecular basis for control of T cell memory
海外基金